NCT02961556View on ClinicalTrials.gov

General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

June 9, 2017

Study Completion Date

August 4, 2017

Conditions
Chronic Constipation
Interventions
DRUG

AJG555

Participants will receive 1 to 6 sachets daily per participants' age and conditions.

Trial Locations (11)

Unknown

EA Pharma Trial Site #1, Yokohama

EA Pharma Trial Site #2, Yokohama

EA Pharma Trial Site #1, Bunkyo

EA Pharma Trial Site #1, Hutyu

EA Pharma Trial Site #1, Ōta-ku

EA Pharma Trial Site #1, Setagaya City

EA Pharma Trial Site #2, Setagaya City

EA Pharma Trial Site #1, Shinjuku

EA Pharma Trial Site #2, Shinjuku

EA Pharma Trial Site #1, Hiroshima

EA Pharma Trial Site #1, Saitama

All Listed Sponsors
lead

EA Pharma Co., Ltd.

INDUSTRY

NCT02961556 - General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation | Biotech Hunter | Biotech Hunter